Home » Topics » BioWorld Science

BioWorld Science
RSS

Versartis and Aravive Biologics enter merger agreement

June 5, 2018

Interim results presented from phase I trial of PIN-2 in patients with solid tumors

June 5, 2018

FDA accepts NDA filing for bremelanotide for hypoactive sexual desire disorder

June 5, 2018

Evoke submits NDA to the FDA for Gimoti

June 5, 2018

Zenith advances trial of ZEN-3694 in metastatic CRPC into phase II

June 5, 2018

PFK/FBPase 1 inhibitors identified at Merck KGaA

June 5, 2018

First-in-human results from Millennium's TAK-931 in advanced solid tumors

June 5, 2018

Dynavax Technologies presents Toll-like receptor 7/8/9 antagonists

June 5, 2018

GERD candidate X-842 safe and well tolerated in first-in-human study

June 5, 2018

Cyxone chooses to complete acquisition of rabeximod

June 5, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...